EICHORPublic-registry site landscape for NCT07532863, “A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants”, a Diabetes Mellitus, Type 2 study sponsored by Novo Nordisk A/S. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07532863 (registry record) |
| Study title | A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants |
| Official title | A Retrospective Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus Participants in Southeast Asia |
| Sponsor | Novo Nordisk A/S |
| Condition(s) | Diabetes Mellitus, Type 2 |
| Phase | — |
| Listed sites | 6 |
| Site countries | Indonesia, Malaysia, Philippines, Singapore |
Patient-friendly overview of this study: eichor.com/study/NCT07532863.
Eichor generates a preliminary site-risk snapshot for NCT07532863 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Diabetes Mellitus, Type 2 trials
More from Novo Nordisk A/S
← Eichor home · All tracked trials · Diabetes Mellitus, Type 2 studies · Weekly briefs
